Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects
Open Access
- 1 October 2016
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 512 (2) , 343-351
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Regulatory development of geriatric medicines: To GIP or not to GIP?Ageing Research Reviews, 2016
- Medicines Management, Medication Errors and Adverse Medication Events in Older People Referred to a Community Nursing Service: A Retrospective Observational StudyDrugs - Real World Outcomes, 2016
- Evaluation of the ease of taking mini-tablets compared with other tablet formulations in healthy volunteersEuropean Journal of Pharmaceutical Sciences, 2016
- Participation of Older People in Preauthorization Trials of Recently Approved MedicinesJournal of the American Geriatrics Society, 2014
- From molecule to market access: Drug regulatory science as an upcoming disciplineEuropean Journal of Pharmacology, 2013
- Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines StrategyNew England Journal of Medicine, 2012
- Fighting Against Age Discrimination in Clinical TrialsJournal of the American Geriatrics Society, 2010
- Die Rolle des Ausschusses für Humanarzneimittel (CHMP) bei der europäischen zentralen ZulassungBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008
- Europäische Verfahren der gegenseitigen Anerkennung im Bereich der HumanarzneimittelBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008
- "Avoid the crush": hazards of medication administration in patients with dysphagia or a feeding tubeCanadian Medical Association Journal, 2005